EPA-话题@MedSci

#EPA#

1120篇内容 | 2814人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1427573, encodeId=ca65142e5733c, content=<a href='/topic/show?id=221d685172' target=_blank style='color:#2F92EE;'>#EPA#</a>, objectTitle=Hepatology：降糖药和血糖控制情况对非酒精性脂肪肝患者肝癌风险的影响, objectType=article, longId=220537, objectId=6cb822053e10, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6cb822053e10, replyNumber=0, likeNumber=69, createdTime=2021-11-19, rootId=0, userName=gwc384, userId=4a9b4077760, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6cb822053e10, moduleTitle=Hepatology：降糖药和血糖控制情况对非酒精性脂肪肝患者肝癌风险的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6cb822053e10)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1427572, encodeId=701f142e57274, content=<a href='/topic/show?id=221d685172' target=_blank style='color:#2F92EE;'>#EPA#</a>, objectTitle=Hepatobiliary Surg Nutr：高HbA1c是肝切除术后并发症的危险因素，并对无肝炎感染的肝细胞癌产生影响, objectType=article, longId=220051, objectId=16f22200518c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=16f22200518c, replyNumber=0, likeNumber=62, createdTime=2021-11-11, rootId=0, userName=gwc384, userId=4a9b4077760, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=16f22200518c, moduleTitle=Hepatobiliary Surg Nutr：高HbA1c是肝切除术后并发症的危险因素，并对无肝炎感染的肝细胞癌产生影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=16f22200518c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1427571, encodeId=233f142e5711a, content=<a href='/topic/show?id=221d685172' target=_blank style='color:#2F92EE;'>#EPA#</a>, objectTitle=J Hepatol：口服FXR激动剂EDP-305治疗非酒精性脂肪性肝炎的疗效, objectType=article, longId=220041, objectId=456022004188, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=456022004188, replyNumber=0, likeNumber=60, createdTime=2021-11-11, rootId=0, userName=gwc384, userId=4a9b4077760, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=456022004188, moduleTitle=J Hepatol：口服FXR激动剂EDP-305治疗非酒精性脂肪性肝炎的疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=456022004188)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1427570, encodeId=3d36142e57076, content=<a href='/topic/show?id=221d685172' target=_blank style='color:#2F92EE;'>#EPA#</a>, objectTitle=Hepatology International：索拉非尼- TACE治疗后难治性不可切除肝细胞癌(HCC)续贯使用阿帕替尼的疗效, objectType=article, longId=219974, objectId=ad462199e46a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ad462199e46a, replyNumber=0, likeNumber=84, createdTime=2021-11-10, rootId=0, userName=gwc384, userId=4a9b4077760, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ad462199e46a, moduleTitle=Hepatology International：索拉非尼- TACE治疗后难治性不可切除肝细胞癌(HCC)续贯使用阿帕替尼的疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ad462199e46a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1427611, encodeId=08ad142e61172, content=<a href='/topic/show?id=221d685172' target=_blank style='color:#2F92EE;'>#EPA#</a>, objectTitle=肝脏肿瘤误诊病例不典型肝癌（atypical hepatocellular carcinoma）, objectType=article, longId=287647, objectId=b46228e6472a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b46228e6472a, replyNumber=0, likeNumber=90, createdTime=2021-11-10, rootId=0, userName=gwc384, userId=4a9b4077760, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b46228e6472a, moduleTitle=肝脏肿瘤误诊病例不典型肝癌（atypical hepatocellular carcinoma）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b46228e6472a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1427569, encodeId=fe56142e56982, content=<a href='/topic/show?id=221d685172' target=_blank style='color:#2F92EE;'>#EPA#</a>, objectTitle=Hepatology：灯盏花素减轻非酒精性脂肪性肝炎的机制研究, objectType=article, longId=219586, objectId=b585219586dd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b585219586dd, replyNumber=0, likeNumber=77, createdTime=2021-11-02, rootId=0, userName=gwc384, userId=4a9b4077760, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b585219586dd, moduleTitle=Hepatology：灯盏花素减轻非酒精性脂肪性肝炎的机制研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b585219586dd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1427568, encodeId=0dbe142e568b8, content=<a href='/topic/show?id=221d685172' target=_blank style='color:#2F92EE;'>#EPA#</a>, objectTitle=柳叶刀：Tirzepatide控制T2DM患者血糖的效果优于胰岛素，且不增加心血管疾病风险！, objectType=article, longId=218901, objectId=20b42189010c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=20b42189010c, replyNumber=0, likeNumber=76, createdTime=2021-10-21, rootId=0, userName=gwc384, userId=4a9b4077760, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=20b42189010c, moduleTitle=柳叶刀：Tirzepatide控制T2DM患者血糖的效果优于胰岛素，且不增加心血管疾病风险！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=20b42189010c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1427567, encodeId=c116142e567a8, content=<a href='/topic/show?id=221d685172' target=_blank style='color:#2F92EE;'>#EPA#</a>, objectTitle=J Hepatol：一种预测韩国和高加索慢性乙型肝炎患者肝细胞癌风险的人工智能模型：PLAN-B, objectType=article, longId=218649, objectId=b92d2186494a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b92d2186494a, replyNumber=0, likeNumber=81, createdTime=2021-10-17, rootId=0, userName=gwc384, userId=4a9b4077760, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b92d2186494a, moduleTitle=J Hepatol：一种预测韩国和高加索慢性乙型肝炎患者肝细胞癌风险的人工智能模型：PLAN-B, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b92d2186494a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1427566, encodeId=d310142e566eb, content=<a href='/topic/show?id=221d685172' target=_blank style='color:#2F92EE;'>#EPA#</a>, objectTitle=J Hepatol：注射毒品人群中丙型肝炎再感染率随着高效直接抗病毒药物(DAA)使用的扩大而同期上升, objectType=article, longId=218647, objectId=89f421864ed3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=89f421864ed3, replyNumber=0, likeNumber=59, createdTime=2021-10-17, rootId=0, userName=gwc384, userId=4a9b4077760, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=89f421864ed3, moduleTitle=J Hepatol：注射毒品人群中丙型肝炎再感染率随着高效直接抗病毒药物(DAA)使用的扩大而同期上升, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=89f421864ed3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1427565, encodeId=55dd142e565d5, content=<a href='/topic/show?id=221d685172' target=_blank style='color:#2F92EE;'>#EPA#</a>, objectTitle=J Hepatol：HCV肝硬化患者持续病毒学应答后肝脏和非肝脏相关结局的发生率, objectType=article, longId=218539, objectId=57a421853972, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=57a421853972, replyNumber=0, likeNumber=89, createdTime=2021-10-15, rootId=0, userName=gwc384, userId=4a9b4077760, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=57a421853972, moduleTitle=J Hepatol：HCV肝硬化患者持续病毒学应答后肝脏和非肝脏相关结局的发生率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=57a421853972)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1427564, encodeId=4d2a142e5648f, content=<a href='/topic/show?id=221d685172' target=_blank style='color:#2F92EE;'>#EPA#</a>, objectTitle=Clin Gastroenterol Hepatol：脂肪胰会大大增加糖尿病患病风险！, objectType=article, longId=218036, objectId=21ad218036d0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=21ad218036d0, replyNumber=0, likeNumber=87, createdTime=2021-10-03, rootId=0, userName=gwc384, userId=4a9b4077760, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=21ad218036d0, moduleTitle=Clin Gastroenterol Hepatol：脂肪胰会大大增加糖尿病患病风险！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=21ad218036d0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1427563, encodeId=d58a142e5630e, content=<a href='/topic/show?id=221d685172' target=_blank style='color:#2F92EE;'>#EPA#</a>, objectTitle=Clin Gastroenterol Hepatol：慢性胰腺炎患者的骨病患病率及风险因素, objectType=article, longId=218035, objectId=a14421803506, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a14421803506, replyNumber=0, likeNumber=78, createdTime=2021-10-03, rootId=0, userName=gwc384, userId=4a9b4077760, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a14421803506, moduleTitle=Clin Gastroenterol Hepatol：慢性胰腺炎患者的骨病患病率及风险因素, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a14421803506)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1427562, encodeId=eff4142e5620f, content=<a href='/topic/show?id=221d685172' target=_blank style='color:#2F92EE;'>#EPA#</a>, objectTitle=Lancet Gastroenterol Hepatol：非酒精性脂肪肝越严重，心血管事件风险越高！, objectType=article, longId=218032, objectId=3b772180325b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3b772180325b, replyNumber=0, likeNumber=36, createdTime=2021-10-03, rootId=0, userName=gwc384, userId=4a9b4077760, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3b772180325b, moduleTitle=Lancet Gastroenterol Hepatol：非酒精性脂肪肝越严重，心血管事件风险越高！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3b772180325b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1427561, encodeId=2b79142e561dc, content=<a href='/topic/show?id=221d685172' target=_blank style='color:#2F92EE;'>#EPA#</a>, objectTitle=J HEPATOLOGY: 抗TNF-α药物——英夫利昔单抗会引起的肝功能损伤, objectType=article, longId=217904, objectId=18a521e904e6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=18a521e904e6, replyNumber=0, likeNumber=76, createdTime=2021-10-01, rootId=0, userName=gwc384, userId=4a9b4077760, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=18a521e904e6, moduleTitle=J HEPATOLOGY: 抗TNF-α药物——英夫利昔单抗会引起的肝功能损伤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=18a521e904e6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1427560, encodeId=61e3142e56001, content=<a href='/topic/show?id=221d685172' target=_blank style='color:#2F92EE;'>#EPA#</a>, objectTitle=HEPATOLOGY：HBV 感染不会增加 COVID-19 患者的死亡率, objectType=article, longId=217903, objectId=f12821e903f8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f12821e903f8, replyNumber=0, likeNumber=105, createdTime=2021-10-01, rootId=0, userName=gwc384, userId=4a9b4077760, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f12821e903f8, moduleTitle=HEPATOLOGY：HBV 感染不会增加 COVID-19 患者的死亡率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f12821e903f8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1427559, encodeId=c45e142e5590b, content=<a href='/topic/show?id=221d685172' target=_blank style='color:#2F92EE;'>#EPA#</a>, objectTitle=J HEPATOLOGY：尿液中肝脏脂肪酸结合蛋白(L-FABP)是失代偿期肝硬化患者慢性肝衰竭和死亡率的预后生物标志物, objectType=article, longId=217902, objectId=5acc21e902a0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5acc21e902a0, replyNumber=0, likeNumber=89, createdTime=2021-10-01, rootId=0, userName=gwc384, userId=4a9b4077760, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5acc21e902a0, moduleTitle=J HEPATOLOGY：尿液中肝脏脂肪酸结合蛋白(L-FABP)是失代偿期肝硬化患者慢性肝衰竭和死亡率的预后生物标志物, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5acc21e902a0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1427558, encodeId=24f7142e558f2, content=<a href='/topic/show?id=221d685172' target=_blank style='color:#2F92EE;'>#EPA#</a>, objectTitle=J HEPATOLOGY：利福昔明可以减少肝硬化和肝性脑病患者的肠道源性炎症和粘蛋白降解程度, objectType=article, longId=217901, objectId=fb4121e901fc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fb4121e901fc, replyNumber=0, likeNumber=88, createdTime=2021-10-01, rootId=0, userName=gwc384, userId=4a9b4077760, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fb4121e901fc, moduleTitle=J HEPATOLOGY：利福昔明可以减少肝硬化和肝性脑病患者的肠道源性炎症和粘蛋白降解程度, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fb4121e901fc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1427557, encodeId=6402142e557a2, content=<a href='/topic/show?id=221d685172' target=_blank style='color:#2F92EE;'>#EPA#</a>, objectTitle=J HEPATOLOGY：索拉非尼能改善HCV相关的肝细胞癌患者的肿瘤生长速度和肝功能, objectType=article, longId=217900, objectId=485421e90077, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=485421e90077, replyNumber=0, likeNumber=70, createdTime=2021-10-01, rootId=0, userName=gwc384, userId=4a9b4077760, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=485421e90077, moduleTitle=J HEPATOLOGY：索拉非尼能改善HCV相关的肝细胞癌患者的肿瘤生长速度和肝功能, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=485421e90077)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1427556, encodeId=7c30142e5568f, content=<a href='/topic/show?id=221d685172' target=_blank style='color:#2F92EE;'>#EPA#</a>, objectTitle=Clinical Gastroenterology Hepatology: 二甲双胍对糖尿病和肝硬化患者生存率的影响, objectType=article, longId=217649, objectId=f7b621e649bb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f7b621e649bb, replyNumber=0, likeNumber=78, createdTime=2021-09-27, rootId=0, userName=gwc384, userId=4a9b4077760, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f7b621e649bb, moduleTitle=Clinical Gastroenterology Hepatology: 二甲双胍对糖尿病和肝硬化患者生存率的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f7b621e649bb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1427555, encodeId=7292142e5557e, content=<a href='/topic/show?id=221d685172' target=_blank style='color:#2F92EE;'>#EPA#</a>, objectTitle=Clin Gastroenterol Hepatol：抗病毒治疗时的HBeAg状态对慢性乙肝患者患肝癌风险的影响, objectType=article, longId=216950, objectId=dc6821695029, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=dc6821695029, replyNumber=0, likeNumber=80, createdTime=2021-09-12, rootId=0, userName=gwc384, userId=4a9b4077760, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=dc6821695029, moduleTitle=Clin Gastroenterol Hepatol：抗病毒治疗时的HBeAg状态对慢性乙肝患者患肝癌风险的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=dc6821695029)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

EPA

2020-05-29

gwc384 (审核中...)

前往app查看评论内容

#EPA#

Hepatology：降糖药和血糖控制情况对非酒精性脂肪肝患者肝癌风险的影响

2021-11-19

gwc384 (审核中...)

前往app查看评论内容

#EPA#

Hepatobiliary Surg Nutr：高HbA1c是肝切除术后并发症的危险因素，并对无肝炎感染的肝细胞癌产生影响

2021-11-11

gwc384 (审核中...)

前往app查看评论内容

#EPA#

J Hepatol：口服FXR激动剂EDP-305治疗非酒精性脂肪性肝炎的疗效

2021-11-11

gwc384 (审核中...)

前往app查看评论内容

#EPA#

Hepatology International：索拉非尼- TACE治疗后难治性不可切除肝细胞癌(HCC)续贯使用阿帕替尼的疗效

2021-11-10

gwc384 (审核中...)

前往app查看评论内容

#EPA#

肝脏肿瘤误诊病例不典型肝癌（atypical hepatocellular carcinoma）

2021-11-10

gwc384 (审核中...)

前往app查看评论内容

#EPA#

Hepatology：灯盏花素减轻非酒精性脂肪性肝炎的机制研究

2021-11-02

gwc384 (审核中...)

前往app查看评论内容

#EPA#

柳叶刀：Tirzepatide控制T2DM患者血糖的效果优于胰岛素，且不增加心血管疾病风险！

2021-10-21

gwc384 (审核中...)

前往app查看评论内容

#EPA#

J Hepatol：一种预测韩国和高加索慢性乙型肝炎患者肝细胞癌风险的人工智能模型：PLAN-B

2021-10-17

gwc384 (审核中...)

前往app查看评论内容

#EPA#

J Hepatol：注射毒品人群中丙型肝炎再感染率随着高效直接抗病毒药物(DAA)使用的扩大而同期上升

2021-10-17

gwc384 (审核中...)

前往app查看评论内容

#EPA#

J Hepatol：HCV肝硬化患者持续病毒学应答后肝脏和非肝脏相关结局的发生率

2021-10-15

gwc384 (审核中...)

前往app查看评论内容

#EPA#

Clin Gastroenterol Hepatol：脂肪胰会大大增加糖尿病患病风险！

2021-10-03

gwc384 (审核中...)

前往app查看评论内容

#EPA#

Clin Gastroenterol Hepatol：慢性胰腺炎患者的骨病患病率及风险因素

2021-10-03

gwc384 (审核中...)

前往app查看评论内容

#EPA#

Lancet Gastroenterol Hepatol：非酒精性脂肪肝越严重，心血管事件风险越高！

2021-10-03

gwc384 (审核中...)

前往app查看评论内容

#EPA#

J HEPATOLOGY: 抗TNF-α药物——英夫利昔单抗会引起的肝功能损伤

2021-10-01

gwc384 (审核中...)

前往app查看评论内容

#EPA#

HEPATOLOGY：HBV 感染不会增加 COVID-19 患者的死亡率

2021-10-01

gwc384 (审核中...)

前往app查看评论内容

#EPA#

J HEPATOLOGY：尿液中肝脏脂肪酸结合蛋白(L-FABP)是失代偿期肝硬化患者慢性肝衰竭和死亡率的预后生物标志物

2021-10-01

gwc384 (审核中...)

前往app查看评论内容

#EPA#

J HEPATOLOGY：利福昔明可以减少肝硬化和肝性脑病患者的肠道源性炎症和粘蛋白降解程度

2021-10-01

gwc384 (审核中...)

前往app查看评论内容

#EPA#

J HEPATOLOGY：索拉非尼能改善HCV相关的肝细胞癌患者的肿瘤生长速度和肝功能

2021-10-01

gwc384 (审核中...)

前往app查看评论内容

#EPA#

Clinical Gastroenterology Hepatology: 二甲双胍对糖尿病和肝硬化患者生存率的影响

2021-09-27

gwc384 (审核中...)

前往app查看评论内容

#EPA#

Clin Gastroenterol Hepatol：抗病毒治疗时的HBeAg状态对慢性乙肝患者患肝癌风险的影响

2021-09-12

科室
- - 订阅+
  - 更多科室
工具
服务